13F HOLDINGS REPORT
Camber Capital Management LP
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0001654954-25-005756
Total Value
$2.81B
Positions
32
Other Managers
0
Confidential Omitted
No
Holdings (32)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR S&P 500 ETF TR | SPY | 1,500,000 | $839.1M | 29.81% |
| 2 | ZIMMER BIOMET HOLDINGS INC | ZBH | 2,250,000 | $254.7M | 9.05% |
| 3 | BAXTER INTL INC | 071813109 | 5,750,000 | $196.8M | 6.99% |
| 4 | HUMANA INC | HUM | 725,000 | $191.8M | 6.81% |
| 5 | PFIZER INC | PFE | 6,800,000 | $172.3M | 6.12% |
| 6 | SPDR SER TR | 78464A870 | 2,000,000 | $162.2M | 5.76% |
| 7 | CVS HEALTH CORP | CVS | 2,250,000 | $152.4M | 5.42% |
| 8 | GLOBUS MED INC | GMED | 1,250,000 | $91.5M | 3.25% |
| 9 | PTC THERAPEUTICS INC | PTCT | 1,500,000 | $76.4M | 2.72% |
| 10 | THE CIGNA GROUP | 125523100 | 200,000 | $65.8M | 2.34% |
| 11 | VIATRIS INC | VTRS | 7,500,000 | $65.3M | 2.32% |
| 12 | PFIZER INC | PFE | 2,500,000 | $63.4M | 2.25% |
| 13 | QIAGEN NV | QGEN | 1,400,000 | $56.2M | 2.00% |
| 14 | ASCENDIS PHARMA A/S | ASND | 350,000 | $54.6M | 1.94% |
| 15 | SAREPTA THERAPEUTICS INC | SRPT | 800,000 | $51.1M | 1.81% |
| 16 | BROOKDALE SR LIVING INC | 112463104 | 6,250,000 | $39.1M | 1.39% |
| 17 | GSK PLC | GLAXF | 1,000,000 | $38.7M | 1.38% |
| 18 | BIOMARIN PHARMACEUTICAL INC | BMRN | 500,000 | $35.3M | 1.26% |
| 19 | CONCENTRA GROUP HOLDINGS PAR | CON | 1,600,000 | $34.7M | 1.23% |
| 20 | EVOLENT HEALTH INC | EVH | 3,000,000 | $28.4M | 1.01% |
| 21 | IONIS PHARMACEUTICALS INC | IONS | 725,000 | $21.9M | 0.78% |
| 22 | MYRIAD GENETICS INC | MYGN | 2,350,000 | $20.8M | 0.74% |
| 23 | ZIMVIE INC | 98888T107 | 1,885,000 | $20.4M | 0.72% |
| 24 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 441,000 | $17.2M | 0.61% |
| 25 | DENALI THERAPEUTICS INC | DNLI | 1,250,000 | $17.0M | 0.60% |
| 26 | ANAPTYSBIO INC | ANABV | 750,000 | $13.9M | 0.50% |
| 27 | THERAVANCE BIOPHARMA INC | TBPH | 1,000,000 | $8.9M | 0.32% |
| 28 | 10X GENOMICS INC | TXG | 1,000,000 | $8.7M | 0.31% |
| 29 | INOGEN INC | INGN | 975,000 | $7.0M | 0.25% |
| 30 | STRUCTURE THERAPEUTICS INC | GPCR | 300,000 | $5.2M | 0.18% |
| 31 | ORASURE TECHNOLOGIES INC | OSUR | 900,000 | $3.0M | 0.11% |
| 32 | GENMAB A/S | GNMSF | 50,000 | $979,000 | 0.03% |